Market leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Media releases
PolyPeptide and Donaldson collaborate to develop solvent recovery system for peptide purification
13 May 2024 - MINNEAPOLIS / TORRANCE, Calif. May 13, 2024 – Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and […]
Read moreExpert views
Research article: Synthesis of Peptides by Reactive Extrusion. Application to the Continuous and Solventless Preparation of Aspartame.
25 Apr 2024 - The latest results from an innovative mechanochemical approach to continuous and solventless peptide synthesis. PolyPeptide is dedicated to applying relevant principles of green chemistry to mitigate […]
Read more